v3.26.1
Interim Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2025
Mar. 31, 2025
Current assets    
Cash at banks $ 1,886,341 $ 2,365,532
Accounts receivable, net 1,740,270 1,411,316
Contract assets 5,088,739 2,295,062
Deferred offering costs 463,529
Deposits and prepayments 211,564 2,590
Total current assets 8,926,914 6,538,029
Non-current assets    
Machineries and equipment, net 1,972,307
Prepayments 731,410
Deferred tax assets 23,681 12,829
Total non-current assets 2,727,398 12,829
Total assets 11,654,312 6,550,858
Current liabilities    
Accounts payable (1,383,360) (413,492)
Contract liabilities (871,827)
Due to directors (1,975,617)
Accrued expenses (241,946) (261,750)
Income tax payable (455,947) (439,706)
Total current liabilities (2,953,080) (3,090,565)
Total liabilities (2,953,080) (3,090,565)
Shareholders’ equity    
Ordinary shares, 500,000,000 shares authorized; USD0.0001 par value, 14,225,000 and 12,500,000 shares issued and outstanding, as of September 30, 2025 and March 31, 2025 respectively 1,423 1,250
Additional paid in capital 5,258,089 164,103
Retained earnings 3,441,720 3,294,940
Total shareholders’ equity 8,701,232 3,460,293
Total liabilities and shareholders’ equity $ 11,654,312 $ 6,550,858